Global Mycoplasma Testing Market 2018-2022

  • ID: 4535201
  • Report
  • Region: Global
  • 120 pages
  • TechNavio
OFF
until May 31st 2018
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Agilent Technologies
  • F Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
  • MORE
About Mycoplasma Testing

Mycoplasma testing is performed to detect, remove, and prevent mycoplasma contamination in cell culture. There are various methods to detect mycoplasma contamination such as polymerase chain reaction (PCR), enzymatic methods, direct growth, or specific deoxyribonucleic acid (DNA) staining. Mycoplasma testing is essential for bio-therapeutic and vaccine manufacturing, and biologics produced for clinical research.

The analysts forecast the global mycoplasma testing market to grow at a CAGR of 11.34% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global mycoplasma testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Mycoplasma Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
Market drivers
  • Increasing focus on R&D of biopharmaceuticals
  • For a full, detailed list, view the full report
Market trends
  • Growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Agilent Technologies
  • F Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCTS
  • Segmentation by product
  • Comparison by product
  • Systems
  • Consumables
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY END-USER
  • Segmentation by end-user
  • Pharmaceutical and biotechnology companies
  • CROs
  • Academic research institutes
  • Cell banks
  • Others
PART 10: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Mycoplasma testing market in Americas
  • Mycoplasma testing market in EMEA
  • Mycoplasma testing market in APAC
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
PART 13: MARKET TRENDS
  • Growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies
  • Technological advances
PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
PART 16: APPENDIX
  • List of abbreviations
List of Exhbits
Exhibit 01: Parent market
Exhibit 02: Global microbiology testing market segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global mycoplasma testing market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global mycoplasma testing market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global mycoplasma testing market by product – Market share 2017-2022 (%)
Exhibit 19: Global mycoplasma testing market – Comparison by product
Exhibit 20: Global mycoplasma testing systems market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global mycoplasma testing systems market – Year-over-year growth 2018-2022 (%)
Exhibit 22: Global mycoplasma testing consumables market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global mycoplasma testing consumables market – Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global mycoplasma testing market by end-user – Market share 2017 (%)
Exhibit 27: Global mycoplasma testing market by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Mycoplasma testing market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Mycoplasma testing market in Americas – Year-over-year growth 2018-2022 (%)
Exhibit 31: Top 2 countries in Americas
Exhibit 32: Mycoplasma testing market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Mycoplasma testing market in EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 34: Top 2 countries in EMEA
Exhibit 35: Mycoplasma testing market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Mycoplasma testing market in APAC – Year-over-year growth 2018-2022 (%)
Exhibit 37: Top 2 countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Collaborations between CROs and pharmaceutical companies
Exhibit 40: M&A of vendors in mycoplasma testing market
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Agilent Technologies: Overview
Exhibit 47: Agilent Technologies: Business segments
Exhibit 48: Agilent Technologies: Organizational developments
Exhibit 49: Agilent Technologies: Geographic focus
Exhibit 50: Agilent Technologies: Segment focus
Exhibit 51: Agilent Technologies: Key offerings
Exhibit 52: Agilent Technologies: Key customers
Exhibit 53: F. Hoffmann-La Roche: Overview
Exhibit 54: F. Hoffmann-La Roche: Business segments
Exhibit 55: F. Hoffmann-La Roche: Organizational developments
Exhibit 56: F. Hoffmann-La Roche: Geographic focus
Exhibit 57: F. Hoffmann-La Roche: Segment focus
Exhibit 58: F. Hoffmann-La Roche: Key offerings
Exhibit 59: F. Hoffmann-La Roche: Key customers
Exhibit 60: InvivoGen: Overview
Exhibit 61: InvivoGen: Business segments
Exhibit 62: InvivoGen: Organizational developments
Exhibit 63: InvivoGen: Geographic focus
Exhibit 64: InvivoGen: Segment focus
Exhibit 65: InvivoGen: Key offerings
Exhibit 66: InvivoGen: Key customers
Exhibit 67: Lonza: Overview
Exhibit 68: Lonza: Business segments
Exhibit 69: Lonza: Organizational developments
Exhibit 70: Lonza: Geographic focus
Exhibit 71: Lonza: Segment focus
Exhibit 72: Lonza: Key offerings
Exhibit 73: Lonza: Key customers
Exhibit 74: Merck: Overview
Exhibit 75: Merck: Business segments
Exhibit 76: Merck: Organizational developments
Exhibit 77: Merck: Geographic focus
Exhibit 78: Merck: Segment focus
Exhibit 79: Merck: Key offerings
Exhibit 80: Merck: Key customers
Exhibit 81: Thermo Fisher Scientific: Overview
Exhibit 82: Thermo Fisher Scientific: Business segments
Exhibit 83: Thermo Fisher Scientific: Organizational developments
Exhibit 84: Thermo Fisher Scientific: Geographic focus
Exhibit 85: Thermo Fisher Scientific: Segment focus
Exhibit 86: Thermo Fisher Scientific: Key offerings
Exhibit 87: Thermo Fisher Scientific: Key customers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Agilent Technologies
  • F Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
  • MORE
New Report Released: – Global Mycoplasma Testing Market 2018-2022

The author of the report recognizes the following companies as the key players in the global mycoplasma testing market: Agilent Technologies, F. Hoffmann-La Roche, InvivoGen, Lonza, Merck, and Thermo Fisher Scientific.

Commenting on the report, an analyst from the research team said: “One trend in the market is growing M&A and partnerships between CROs, and pharmaceutical and biotechnology companies. The leading CROs that are currently functioning in the market are IQVIA, Laboratory Corporation of America, Pharmaceutical Product Development, Syneos Health, and PRA Health Sciences.”

According to the report, one driver in the market is increasing focus on R&D of biopharmaceuticals. There is a growing preference for new class therapeutics such as cell therapy and gene therapy for the treatment of several chronic and acute diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Agilent Technologies
  • F Hoffmann-La Roche
  • InvivoGen
  • Lonza
  • Merck
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll